Cathay Biotech Inc. (SHA:688065)

Market Cap	29.54B
Revenue (ttm)	2.96B
Net Income (ttm)	486.73M
Shares Out	581.32M
EPS (ttm)	0.84
PE Ratio	60.49
Forward PE	n/a
Dividend	0.19 (0.37%)
Ex-Dividend Date	Jul 24, 2024

Volume	5,680,576
Average Volume	4,020,823
Open	49.03
Previous Close	48.87
Day's Range	48.99 - 51.47
52-Week Range	32.48 - 56.98
Beta	0.66
RSI	61.24
Earnings Date	Apr 3, 2025

About Cathay Biotech

Cathay Biotech Inc., a bio-manufacturing technology company, researches, develops, produces, and sells bio-based materials in China and internationally. It offers biological long-chain diacids comprising sebacic acid and octadecanedioic acid; bio-based polyamides; and bio-based pentamethylene diamine. The products are used in various applications, including textiles, pharmaceuticals, perfumes, automobiles, electronic appliances, consumer goods, and other industries. It provides its products under the TERRYL and ECOPENT brands. Cathay Biotech In...

• Industry: Chemicals
• Sector: Materials
• Founded: 2000
• Employees: 1,803
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688065

Financial Performance

In 2024, Cathay Biotech's revenue was 2.96 billion, an increase of 39.84% compared to the previous year's 2.11 billion. Earnings were 486.73 million, an increase of 32.80%.